Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2007

01-01-2007

Complications after Extended (D2) and Superextended (D3) Lymphadenectomy for Gastric Cancer: Analysis of Potential Risk Factors

Authors: Daniele Marrelli, MD, Corrado Pedrazzani, MD, Alessandro Neri, MD, Giovanni Corso, MD, Alfonso De Stefano, MD, Enrico Pinto, MD, Franco Roviello, MD

Published in: Annals of Surgical Oncology | Issue 1/2007

Login to get access

Abstract

Background

Very few studies from Western centers have compared D2 and D3 dissection in the surgical treatment of gastric cancer. The aim of the prospective observational study reported here was to analyze the postoperative outcome and potential risk factors for complications following D2 and D3 lymphadenectomy.

Methods

A total of 330 consecutive patients, of which 251 submitted to D2 lymphadenectomy and 79 were treated by D3 lymphadenectomy, were enrolled in the study. Twenty potential risk factors for morbidity and mortality were studied by means of univariate and multivariate analysis.

Results

Overall morbidity and mortality rates were 34% (111 patients) and 4% (14 patients), respectively. Abdominal abscess, anastomotic leakage, pleuropulmonary diseases and pancreatitis were the most commonly observed complications. No differences in morbidity, surgical morbidity, mortality rates and mean hospital stay between D2 and D3 lymphadenectomy were found. Multivariate analysis revealed that American Society of Anesthesiologists’ (ASA) class II/III versus class I, perioperative blood transfusions, and low albumin serum levels were independent predictors of postoperative complications. Age, surgical radicality (R1/R2 vs. R0) and low albumin serum levels independently predicted mortality. Mortality rate was .5% in the 203 patients aged 75 years or younger who underwent curative surgery. Most of deaths were observed in patients older than 75 years with low albumin serum levels or treated by non-curative surgery.

Conclusions

D2 lymphadenectomy represents a feasible procedure associated to acceptable morbidity and mortality rates. In specialized centers, D3 lymphadenectomy may be performed without increasing the risk of postoperative complications and associated deaths in carefully selected patients. These techniques should be avoided in subgroups of patients with a high risk of postoperative mortality.
Literature
1.
go back to reference Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 5th edn. New York: John Wiley & Sons; 1997 Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 5th edn. New York: John Wiley & Sons; 1997
2.
go back to reference Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg1999; 230:170–8PubMedCrossRef Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg1999; 230:170–8PubMedCrossRef
3.
go back to reference de Manzoni G, Verlato G, Roviello F, et al. Italian Research Group for Gastric Cancer. Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum. Gastric Cancer 2003; 6:237–42PubMedCrossRef de Manzoni G, Verlato G, Roviello F, et al. Italian Research Group for Gastric Cancer. Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum. Gastric Cancer 2003; 6:237–42PubMedCrossRef
4.
go back to reference Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 1996; 23:360–8PubMed Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 1996; 23:360–8PubMed
5.
go back to reference Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy–Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767–73PubMedCrossRef Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy–Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767–73PubMedCrossRef
6.
go back to reference Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005; 12:981–7PubMedCrossRef Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005; 12:981–7PubMedCrossRef
7.
go back to reference Brennan MF, Karpeh MS Jr. Surgery for gastric cancer: the American view. Semin Oncol 1996; 23:352–9PubMed Brennan MF, Karpeh MS Jr. Surgery for gastric cancer: the American view. Semin Oncol 1996; 23:352–9PubMed
8.
go back to reference de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83:1604–7PubMedCrossRef de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83:1604–7PubMedCrossRef
9.
go back to reference Siewert JR, Bottcher K, Stein HJ, Roder JD, and the German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449–61PubMedCrossRef Siewert JR, Bottcher K, Stein HJ, Roder JD, and the German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449–61PubMedCrossRef
10.
go back to reference Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 2001; 84:1602–9PubMedCrossRef Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 2001; 84:1602–9PubMedCrossRef
11.
go back to reference Roviello F, Marrelli D, Morgagni P, et al. Italian Research Group for Gastric Cancer. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002; 9:894–900PubMedCrossRef Roviello F, Marrelli D, Morgagni P, et al. Italian Research Group for Gastric Cancer. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002; 9:894–900PubMedCrossRef
12.
go back to reference Bonenkamp JJ, Hermans J, Sasako M, et al. Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340:908–14PubMedCrossRef Bonenkamp JJ, Hermans J, Sasako M, et al. Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340:908–14PubMedCrossRef
13.
go back to reference Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79:1522–30PubMedCrossRef Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79:1522–30PubMedCrossRef
14.
go back to reference Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22:2069–77PubMedCrossRef Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22:2069–77PubMedCrossRef
15.
go back to reference Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 1998; 123:573–8PubMedCrossRef Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 1998; 123:573–8PubMedCrossRef
16.
go back to reference Nakane Y, Okamura S, Masuya Y, Okumura S, Akehira K, Hioki K. Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45:1901–6PubMed Nakane Y, Okamura S, Masuya Y, Okumura S, Akehira K, Hioki K. Incidence and prognosis of para-aortic lymph node metastasis in gastric cancer. Hepatogastroenterology 1998; 45:1901–6PubMed
17.
go back to reference Maeta M, Yamashiro H, Saito H, et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 1999; 125:325–31PubMed Maeta M, Yamashiro H, Saito H, et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 1999; 125:325–31PubMed
18.
go back to reference Takashima S, Kosaka T. Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer. Surg Today 2005; 35:425–31PubMedCrossRef Takashima S, Kosaka T. Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer. Surg Today 2005; 35:425–31PubMedCrossRef
19.
go back to reference Kunisaki C, Akiyama H, Nomura M, et al. Comparison of Surgical Results of D2 Versus D3 Gastrectomy (Para-Aortic Lymph Node Dissection) for Advanced Gastric Carcinoma: A Multi-Institutional Study. Ann Surg Oncol 2006; 13:836–42PubMedCrossRef Kunisaki C, Akiyama H, Nomura M, et al. Comparison of Surgical Results of D2 Versus D3 Gastrectomy (Para-Aortic Lymph Node Dissection) for Advanced Gastric Carcinoma: A Multi-Institutional Study. Ann Surg Oncol 2006; 13:836–42PubMedCrossRef
20.
go back to reference Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005; 2:98–107PubMedCrossRef Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005; 2:98–107PubMedCrossRef
21.
go back to reference Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F; Italian Research Group for Gastric Cancer. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005; 241:247–55PubMedCrossRef Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F; Italian Research Group for Gastric Cancer. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005; 241:247–55PubMedCrossRef
22.
go back to reference Cunningham D, Allum WH, Stenning SP, Weeden S, for the NCRI Upper GI Cancer Clinical Studies Group. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). J Clin Oncol (Meeting Abstracts) 2005;23[Suppl]:4001 Cunningham D, Allum WH, Stenning SP, Weeden S, for the NCRI Upper GI Cancer Clinical Studies Group. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). J Clin Oncol (Meeting Abstracts) 2005;23[Suppl]:4001
23.
go back to reference Fatouros M, Roukos DH, Lorenz M, Arampatzis I, Hottentrott C, Encke A, Kappas AM. Impact of spleen preservation in patients with gastric cancer. Anticancer Res 2005; 25:3023–30PubMed Fatouros M, Roukos DH, Lorenz M, Arampatzis I, Hottentrott C, Encke A, Kappas AM. Impact of spleen preservation in patients with gastric cancer. Anticancer Res 2005; 25:3023–30PubMed
24.
go back to reference Roukos DH. Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 2002; 9:620–1 Roukos DH. Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 2002; 9:620–1
25.
go back to reference Gunther K, Horbach T, Merkel S, Meyer M, Schnell U, Klein P, Hohenberger W. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000; 30:700–5PubMedCrossRef Gunther K, Horbach T, Merkel S, Meyer M, Schnell U, Klein P, Hohenberger W. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000; 30:700–5PubMedCrossRef
26.
go back to reference Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol 2004; 30:20–5PubMedCrossRef Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol 2004; 30:20–5PubMedCrossRef
27.
go back to reference Japanese Research Society for Gastric Cancer: Japanese classification of gastric carcinoma - 1st English edition. (1995) Tokyo: Kanehara & co Japanese Research Society for Gastric Cancer: Japanese classification of gastric carcinoma - 1st English edition. (1995) Tokyo: Kanehara & co
28.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma – 2nd English edition. Gastric Cancer 1998; 1:10–24PubMedCrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma – 2nd English edition. Gastric Cancer 1998; 1:10–24PubMedCrossRef
29.
go back to reference Marrelli D, Roviello F, De Stefano A, Vuolo G, Brandi C, Lottini M, Pinto E. Surgical treatment of gastrointestinal carcinomas in octogenarians: risk factors for complications and long-term outcome. Eur J Surg Oncol 2000; 26:371–6PubMedCrossRef Marrelli D, Roviello F, De Stefano A, Vuolo G, Brandi C, Lottini M, Pinto E. Surgical treatment of gastrointestinal carcinomas in octogenarians: risk factors for complications and long-term outcome. Eur J Surg Oncol 2000; 26:371–6PubMedCrossRef
30.
go back to reference Golub R, Golub RW, Cantu R Jr, Stein HD. A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 1997; 184:364–2PubMed Golub R, Golub RW, Cantu R Jr, Stein HD. A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg 1997; 184:364–2PubMed
31.
go back to reference Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92:1103–9PubMedCrossRef Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92:1103–9PubMedCrossRef
32.
go back to reference de Manzoni G, Verlato G, Roviello F, et al. Italian Research Group for Gastric Cancer. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002; 87:171–4PubMedCrossRef de Manzoni G, Verlato G, Roviello F, et al. Italian Research Group for Gastric Cancer. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002; 87:171–4PubMedCrossRef
33.
go back to reference Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90:1727–32PubMed Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90:1727–32PubMed
34.
go back to reference Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91:283–7PubMedCrossRef Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91:283–7PubMedCrossRef
35.
go back to reference Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237:860–9PubMedCrossRef Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237:860–9PubMedCrossRef
36.
go back to reference Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134:36–42PubMedCrossRef Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134:36–42PubMedCrossRef
37.
go back to reference Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 2002; 18:953–9PubMedCrossRef Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 2002; 18:953–9PubMedCrossRef
38.
go back to reference Miner TJ, Jaques DP, Karpeh MS, Brennan MF. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 2004; 198:1013–21PubMedCrossRef Miner TJ, Jaques DP, Karpeh MS, Brennan MF. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 2004; 198:1013–21PubMedCrossRef
39.
go back to reference Baba H, Maehara Y, Inutsuka S, Takeuchi H, Oshiro T, Adachi Y, Sugimachi K. Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg 1995; 169:261–4PubMedCrossRef Baba H, Maehara Y, Inutsuka S, Takeuchi H, Oshiro T, Adachi Y, Sugimachi K. Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg 1995; 169:261–4PubMedCrossRef
Metadata
Title
Complications after Extended (D2) and Superextended (D3) Lymphadenectomy for Gastric Cancer: Analysis of Potential Risk Factors
Authors
Daniele Marrelli, MD
Corrado Pedrazzani, MD
Alessandro Neri, MD
Giovanni Corso, MD
Alfonso De Stefano, MD
Enrico Pinto, MD
Franco Roviello, MD
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 1/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9063-3

Other articles of this Issue 1/2007

Annals of Surgical Oncology 1/2007 Go to the issue

Letter to the Editor

Poor Prognosis for Biomarkers